TickerFacts.

A business in context

CVS research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-08-13 · 0001193125-26-354096 · Items 5.02,7.01,9.01

  2. 10-Q · Quarterly report

    Report date 2026-06-30 · 0000064803-26-000098

  3. 8-K · Current report

    Report date 2026-08-05 · 0000064803-26-000097 · Items 2.02,9.01

  4. 4 · Ownership change

    Report date 2026-06-26 · 0000064803-26-000092

  5. 4 · Ownership change

    Report date 2026-05-31 · 0000064803-26-000088

  6. 4 · Ownership change

    Report date 2026-05-31 · 0000064803-26-000086

  7. 4 · Ownership change

    Report date 2026-05-20 · 0000064803-26-000084

  8. 4 · Ownership change

    Report date 2026-05-19 · 0000905148-26-002617

  9. 8-K · Current report

    Report date 2026-05-14 · 0000064803-26-000082 · Items 5.02,5.07

  10. 4 · Ownership change

    Report date 2026-05-14 · 0000064803-26-000080

  11. 4 · Ownership change

    Report date 2026-05-14 · 0000064803-26-000078

  12. 4 · Ownership change

    Report date 2026-05-14 · 0000064803-26-000076

  13. 10-Q · Quarterly report

    Report date 2026-03-31 · 0000064803-26-000052

  14. 8-K · Current report

    Report date 2026-05-06 · 0000064803-26-000051 · Items 2.02,9.01

  15. DEF 14A · Proxy statement

    Report date 2026-05-14 · 0001308179-26-000201

  16. 8-K · Current report

    Report date 2026-03-18 · 0000064803-26-000017 · Items 5.02

  17. 10-K · Annual report

    Report date 2025-12-31 · 0000064803-26-000010

  18. 8-K · Current report

    Report date 2026-02-10 · 0000064803-26-000009 · Items 2.02,9.01

  19. 8-K · Current report

    Report date 2025-12-09 · 0000064803-25-000082 · Items 7.01,9.01

  20. 8-K · Current report

    Report date 2025-11-20 · 0001193125-25-289805 · Items 8.01,9.01

  21. 10-Q · Quarterly report

    Report date 2025-09-30 · 0000064803-25-000037

  22. 8-K · Current report

    Report date 2025-10-29 · 0000064803-25-000036 · Items 2.02,9.01

  23. 8-K · Current report

    Report date 2025-09-22 · 0001193125-25-211349 · Items 8.01,9.01

  24. 8-K · Current report

    Report date 2025-08-11 · 0001193125-25-181862 · Items 8.01,9.01

  25. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000064803-25-000024

  26. 8-K · Current report

    Report date 2025-07-31 · 0000064803-25-000023 · Items 2.02,9.01

  27. 8-K · Current report

    Report date 2025-05-15 · 0000064803-25-000015 · Items 5.07

  28. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000064803-25-000013

  29. 8-K · Current report

    Report date 2025-05-01 · 0000064803-25-000012 · Items 2.02,9.01

  30. 8-K · Current report

    Report date 2025-04-07 · 0001193125-25-075089 · Items 5.02,7.01,9.01

  31. DEF 14A · Proxy statement

    Report date 2025-05-15 · 0001308179-25-000386

  32. 10-K · Annual report

    Report date 2024-12-31 · 0000064803-25-000007

  33. 8-K · Current report

    Report date 2025-02-12 · 0000064803-25-000006 · Items 2.02,9.01

  34. 8-K · Current report

    Report date 2024-12-16 · 0001193125-24-279907 · Items 8.01,9.01

  35. 8-K · Current report

    Report date 2024-12-10 · 0001193125-24-274362 · Items 8.01,9.01

  36. 8-K · Current report

    Report date 2024-12-09 · 0001193125-24-272865 · Items 8.01,9.01

  37. 8-K · Current report

    Report date 2024-12-06 · 0001193125-24-272437 · Items 8.01,9.01

  38. 8-K · Current report

    Report date 2024-12-03 · 0001193125-24-270867 · Items 8.01,9.01

  39. 8-K · Current report

    Report date 2024-12-02 · 0001193125-24-268490 · Items 8.01,9.01

  40. 8-K · Current report

    Report date 2024-11-12 · 0001193125-24-260405 · Items 1.01,5.02,7.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 9 transaction rows9SGrant / award: 29 transaction rows29AExercise / conversion: 0 transaction rows0MTax / exercise payment: 10 transaction rows10FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

50 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-26
2026-06-29
Clark James DavidF · Tax / exercise payment
Disposed
Common Stock (Restricted)454.090.98
2026-05-31
2026-06-01
Newman BrianF · Tax / exercise payment
Disposed
Common Stock2478.090.98
2026-05-31
2026-06-01
Compton-Phillips AmyF · Tax / exercise payment
Disposed
Common Stock7618.090.98
2026-05-21
2026-05-21
ROBBINS LARRYS · Sale
Disposed
Common Stock370462.093.45
2026-05-21
2026-05-21
ROBBINS LARRYS · Sale
Disposed
Cash-Settled Swaps
Derivative security
378000.093.31
2026-05-21
2026-05-22
AGUIRRE FERNANDOD · Disposition to issuer
Disposed
Common Stock1563.093.5
2026-05-20
2026-05-21
ROBBINS LARRYS · Sale
Disposed
Common Stock66881.095.67
2026-05-20
2026-05-21
ROBBINS LARRYS · Sale
Disposed
Common Stock800.096.28
2026-05-20
2026-05-21
ROBBINS LARRYS · Sale
Disposed
Common Stock797628.093.48
2026-05-20
2026-05-21
ROBBINS LARRYS · Sale
Disposed
Common Stock152691.094.81
2026-05-20
2026-05-22
AGUIRRE FERNANDOD · Disposition to issuer
Disposed
Common Stock30437.093.78
2026-05-19
2026-05-21
ROBBINS LARRYS · Sale
Disposed
Common Stock1983387.094.45
2026-05-19
2026-05-21
ROBBINS LARRYS · Sale
Disposed
Common Stock151.095.18
2026-05-14
2026-05-15
Gallina John EA · Grant / award
Acquired
Deferred Stock Units
Derivative security
1447.597.15
2026-05-14
2026-05-15
Mahoney Michael FA · Grant / award
Acquired
Deferred Stock Units
Derivative security
1737.097.15
2026-05-14
2026-05-15
AGUIRRE FERNANDOA · Grant / award
Acquired
Common Stock1563.097.15
2026-05-14
2026-05-15
Balser Jeffrey R.A · Grant / award
Acquired
Common Stock2058.097.15
2026-05-14
2026-05-15
KIRBY J SCOTTA · Grant / award
Acquired
Common Stock1447.097.15
2026-05-14
2026-05-15
Norwalk Leslie VA · Grant / award
Acquired
Common Stock1447.097.15
2026-05-14
2026-05-15
SANSONE GUY PA · Grant / award
Acquired
Common Stock1447.097.15
2026-05-14
2026-05-15
DECOUDREAUX ALECIA AA · Grant / award
Acquired
Deferred Stock Units
Derivative security
1447.597.15
2026-05-14
2026-05-15
Finucane Anne A.A · Grant / award
Acquired
Deferred Stock Units
Derivative security
1544.097.15
2026-05-14
2026-05-15
BROWN C DAVID IIA · Grant / award
Acquired
Common Stock1544.097.15
2026-05-14
2026-05-15
Shulman Douglas H.A · Grant / award
Acquired
Deferred Stock Units
Derivative security
1447.597.15
2026-05-14
2026-05-15
ROBBINS LARRYA · Grant / award
Acquired
Deferred Stock Units
Derivative security
1930.0197.15
2026-05-08
2026-05-11
Mandadi TilakS · Sale
Disposed
Common Stock69551.089.58
2026-04-01
2026-04-02
Shah Prem SF · Tax / exercise payment
Disposed
Common Stock1484.072.49
2026-04-01
2026-04-02
Nelson Steven HF · Tax / exercise payment
Disposed
Common Stock2432.072.49
2026-04-01
2026-04-02
Mandadi TilakF · Tax / exercise payment
Disposed
Common Stock3634.072.49
2026-04-01
2026-04-02
Khichi Samrat S.F · Tax / exercise payment
Disposed
Common Stock3541.072.49
2026-04-01
2026-04-02
Joyner J. DavidF · Tax / exercise payment
Disposed
Common Stock8029.072.49
2026-04-01
2026-04-02
Clark James DavidF · Tax / exercise payment
Disposed
Common Stock3262.072.49
2026-04-01
2026-04-02
CAPOZZI HEIDI BF · Tax / exercise payment
Disposed
Common Stock1334.072.49
2026-03-31
2026-04-02
Shah Prem SA · Grant / award
Acquired
Common Stock (Restricted)25062.071.82
2026-03-31
2026-04-02
Shah Prem SA · Grant / award
Acquired
Stock Option
Derivative security
161676.071.82
2026-03-31
2026-04-02
Newman BrianA · Grant / award
Acquired
Common Stock (RSUs)19493.071.82
2026-03-31
2026-04-02
Newman BrianA · Grant / award
Acquired
Stock Option
Derivative security
125748.071.82
2026-03-31
2026-04-02
Nelson Steven HA · Grant / award
Acquired
Common Stock (Restricted)22277.071.82
2026-03-31
2026-04-02
Nelson Steven HA · Grant / award
Acquired
Stock Option
Derivative security
143712.071.82
2026-03-31
2026-04-02
Mandadi TilakA · Grant / award
Acquired
Common Stock (RSUs)22277.071.82
2026-03-31
2026-04-02
Mandadi TilakA · Grant / award
Acquired
Stock Option
Derivative security
143712.071.82
2026-03-31
2026-04-02
Khichi Samrat S.A · Grant / award
Acquired
Common Stock (Restricted)12531.071.82
2026-03-31
2026-04-02
Khichi Samrat S.A · Grant / award
Acquired
Stock Option
Derivative security
80838.071.82
2026-03-31
2026-04-02
Joyner J. DavidA · Grant / award
Acquired
Common Stock (RSUs)86326.071.82
2026-03-31
2026-04-02
Compton-Phillips AmyA · Grant / award
Acquired
Common Stock (RSUs)5569.071.82
2026-03-31
2026-04-02
Compton-Phillips AmyA · Grant / award
Acquired
Stock Option
Derivative security
35928.071.82
2026-03-31
2026-04-02
Clark James DavidA · Grant / award
Acquired
Common Stock (Restricted)11138.071.82
2026-03-31
2026-04-02
Clark James DavidA · Grant / award
Acquired
Stock Option
Derivative security
11976.071.82
2026-03-31
2026-04-02
CAPOZZI HEIDI BA · Grant / award
Acquired
Common Stock (Restricted)10025.071.82
2026-03-31
2026-04-02
CAPOZZI HEIDI BA · Grant / award
Acquired
Stock Option
Derivative security
64670.071.82

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000064803CVS HEALTH Corp
MinuteClinicLongs DrugsCVS CaremarkAetna

Showing 4 of 4 imported Wikidata subsidiary claims. Additional aliases appear below.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
549300EJG376EN5NQE29
GLEIF legal name
CVS HEALTH CORPORATION
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2026-03-04T12:56:32Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • CVS Health · alias · wikidata
  • CVS Health (United States) · alias · wikidata
  • CVS Health Corporation · alias · wikidata
  • MinuteClinic · subsidiary · wikidata
  • Minute Clinic · subsidiary · wikidata
  • Longs Drugs · subsidiary · wikidata
  • Longs · subsidiary · wikidata
  • CVS Caremark · subsidiary · wikidata
  • Caremark Rx · subsidiary · wikidata
  • CVS/caremark · subsidiary · wikidata
  • CVScaremark · subsidiary · wikidata
  • Aetna · subsidiary · wikidata
  • Aetna Inc. · subsidiary · wikidata
  • CVS CAREMARK CORP · former SEC name · 2006-12-27 to 2014-09-03
  • CVS/CAREMARK CORP · former SEC name · 2007-03-23 to 2007-05-08
  • CVS CORP · former SEC name · 1997-02-07 to 2007-03-22
  • MELVILLE CORP · former SEC name · 1994-03-31 to 1997-01-10
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$372.81B$396.84B
2023-12-31$357.78B$392.06B
2022-12-31$322.47B$367.87B
2021-12-31$292.11B$359.91B
2020-12-31$268.71B$346.68B
2019-12-31$256.78B$335.36B
2018-12-31$194.58B$258.74B
2017-12-31$184.79B$251.72B

Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

Explore the CPI history ↗